CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS

被引:1588
|
作者
ARTURSSON, P
KARLSSON, J
机构
[1] Department of Pharmaceutics, Uppsala University, S-751 23 Uppsala
关键词
D O I
10.1016/0006-291X(91)91647-U
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium. Absorption rate constants (expressed as apparent permeability coefficients) were determined for 20 drugs and peptides with different structural properties. The permeability coefficients ranged from approximately 5 × 10-8 to 5 × 10-5 cm/s. A good correlation was obtained between data on aral absorption in humans and the results in the Caco-2 model. Drugs that are completely absorbed in humans had permeability coefficients > 1 × 10-6 cm/s. Drugs that are absorbed to > 1% but < 100% had permeability coefficients of 0.1-1.0 × 10-6 cm/s while drugs and peptides that are absorbed to < 1% had permeability coefficients ≤ 1 × 10-7 cm/s. The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption. © 1991.
引用
收藏
页码:880 / 885
页数:6
相关论文
共 50 条
  • [1] Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line
    Marie-Catherine Grès
    Bernard Julian
    Martine Bourrié
    Viviane Meunier
    Claude Roques
    Marion Berger
    Xavier Boulenc
    Yves Berger
    Gérard Fabre
    Pharmaceutical Research, 1998, 15 : 726 - 733
  • [2] Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line:: Comparison with the parental Caco-2 cell line
    Grès, MC
    Julian, B
    Bourrié, M
    Meunier, V
    Roques, C
    Berger, M
    Boulenc, X
    Berger, Y
    Fabre, G
    PHARMACEUTICAL RESEARCH, 1998, 15 (05) : 726 - 733
  • [3] Application of a Human Intestinal Epithelial Cell Monolayer to the Prediction of Oral Drug Absorption in Humans as a Superior Alternative to the Caco-2 Cell Monolayer
    Takenaka, Toru
    Harada, Naomoto
    Kuze, Jiro
    Chiba, Masato
    Iwao, Takahiro
    Matsunaga, Tamihide
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) : 915 - 924
  • [4] Link between drug absorption solubility and permeability measurements in Caco-2 cells
    Pade, V
    Stavchansky, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (12) : 1604 - 1607
  • [5] Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
    Hubatsch, Ina
    Ragnarsson, Eva G. E.
    Artursson, Per
    NATURE PROTOCOLS, 2007, 2 (09) : 2111 - 2119
  • [6] Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
    Ina Hubatsch
    Eva G E Ragnarsson
    Per Artursson
    Nature Protocols, 2007, 2 : 2111 - 2119
  • [7] Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells
    Yamashita, S
    Furubayashi, T
    Kataoka, M
    Sakane, T
    Sezaki, H
    Tokuda, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (03) : 195 - 204
  • [8] Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo
    Lennernas, H
    Palm, K
    Fagerholm, U
    Artursson, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (01) : 103 - 107
  • [9] Relationship between structure and permeability of tryptophan derivatives across human intestinal epithelial (Caco-2) cells
    Urakami, M
    Ano, R
    Kimura, Y
    Shima, M
    Matsuno, R
    Ueno, T
    Akamatsu, M
    ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES, 2003, 58 (1-2): : 135 - 142
  • [10] Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments
    Nicholas G. Lamson
    Rebecca L. Ball
    Katherine C. Fein
    Kathryn A. Whitehead
    Pharmaceutical Research, 2019, 36